Ovarian function suppression is not indispensable in patients with early breast cancer who are older than age 40.

Authors

null

Jianqiao Xian

Sun Yat-Sen University Cancer Center, Guangzhou, China

Jianqiao Xian , Kaiming Zhang , Ya Sun , Yan Wang , Xinhua Xie , Feng Ye , Xing Li , Jun Yin , Weidong Wei , Xiangsheng Xiao , Xiaoming Xie , Xi Wang , Jun Tang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 539)

DOI

10.1200/JCO.2022.40.16_suppl.539

Abstract #

539

Poster Bd #

311

Abstract Disclosures